FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1352511000001102: Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1877261000001115 Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1877271000001113 Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Is a Sotalol 160mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Is pack of Sotalol 160mg tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has active ingredient Sotalol hydrochloride false Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has AMP Sotalol 160mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Sotalol hydrochloride true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Sotalol 160mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start